ALXN
Alexion Pharmaceuticals Inc
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
595 hedge funds and large institutions have $30B invested in Alexion Pharmaceuticals Inc in 2017 Q3 according to their latest regulatory filings, with 88 funds opening new positions, 218 increasing their positions, 214 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
595
Holders Change
+36
Holders Change %
+6.44%
% of All Funds
14.86%
Holding in Top 10
19
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.47%
New
88
Increased
218
Reduced
214
Closed
45
Calls
$551M
Puts
$435M
Net Calls
+$117M
Net Calls Change
-$98.3M
Top Buyers
Top Sellers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$2.66B |
| 2 |
2
Sands Capital Management
Arlington,
Virginia
|
$670M |
| 3 |
3
Goldman Sachs
New York
|
$485M |
| 4 |
4
State Street
Boston,
Massachusetts
|
$1.58B |
| 5 |
5
BlackRock
New York
|
$2.72B |
